Anthem invests in AI-enabled telehealth platform

K Health, a startup offering patients an artificial intelligence-powered symptom checker and telehealth consultations with primary care physicians, raised $48 million from investors that included its partner Anthem, Crunchbase reports.

Advertisement

Consultations with the platform begin with an AI analysis of patients’ symptoms, after which they can be transferred to an on-call doctor for diagnosis and any necessary prescriptions or lab test orders. Individual consultations cost $14, or patients can opt in to an annual subscription for $39.

The Series C fundraise will reportedly support K Health’s expansion efforts, including making the app available in more languages in the coming weeks.

Anthem began integrating K Health’s technology into its own CareSpree telehealth app in July 2019, The Wall Street Journal reported at the time. The app is available to patients both in and outside of the Anthem network and allows them to pay for their primary care consultations directly within the app.

More articles on telehealth:
Viewpoint: Telemedicine needs 5G before it can transform healthcare
Viewpoint: Why telehealth is ‘the Netflix of medicine’
Teladoc Health welcomes Froedtert Health CEO to board of directors

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

How Allina Health is building the operating system for AI transformation — and driving $7.3M in added annual surgical contribution margin

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: William Evans, Allina HealthDonna Sajady, Allina HealthDavid Atashroo, MD, Qventus

Advertisement

Next Up in Telehealth

Advertisement

Comments are closed.